Abstract
Randomized trials have demonstrated that drug eluting balloon (DEB) angioplasty plus bare-metal stenting is non-inferior to drug eluting stenting in dealing with de-novo lesions. The efficacy and safety of the DEB for treatment of de-novo coronary artery disease in a large-scale registry has been
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
